Does diarrhea predominant irritable bowel syndrome really exist?

被引:0
|
作者
Seelis, REA
Dohmen, W
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
4055
引用
收藏
页码:A755 / A755
页数:1
相关论文
共 50 条
  • [1] Emerging drug for diarrhea predominant irritable bowel syndrome
    Deiana, Simona
    Gabbani, Tommaso
    Bagnoli, Siro
    Annese, Vito
    EXPERT OPINION ON EMERGING DRUGS, 2015, 20 (02) : 247 - 261
  • [2] Diarrhea- and constipation-predominant irritable bowel syndrome
    Richard Lea
    Peter J. Whorwell
    Current Treatment Options in Gastroenterology, 2001, 4 (4) : 299 - 308
  • [3] Role of Diet in Diarrhea-predominant Irritable Bowel Syndrome
    Singh, Prashant
    Nee, Judy
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2021, 55 (01) : 25 - 29
  • [4] Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome
    Kane, John S.
    Ford, Alexander C.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (04) : 431 - 442
  • [5] The intestinal microbiome of diarrhea-predominant irritable bowel syndrome
    Carroll, I. M.
    Ringel-Kulka, T.
    Siddle, J. P.
    Ringel, Y.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2011, 23 : 13 - 13
  • [6] New treatment options for irritable bowel syndrome with predominant diarrhea
    Weber, H. Christian
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2017, 24 (01) : 25 - 30
  • [7] Irritable Bowel Syndrome with predominant diarrhea and giardiasis: is it one or the other?
    Sebastian Domingo, Juan J.
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2018, 41 (10): : 647 - 648
  • [8] Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome
    Lacy, Brian E.
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2016, 9 : 7 - 17
  • [9] Targeted therapies for diarrhea-predominant irritable bowel syndrome
    Olden, Kevin W.
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2012, 5 : 69 - 100
  • [10] Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
    Ozdener, Ayse Elif
    Rivkin, Anastasia
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 2827 - 2840